IL37 and COVID-19: In this study, we utilized a mouse model of SARS‐CoV‐2 infection to investigate the inhibitory role of IL‐37 in pneumonia caused by SARS‐CoV‐2 infection and explored the target cells and molecular mechanisms to identify novel therapeutic strategies for the clinical prevention and treatment of COVID‐19.